At 09:15 am, around 6.76 million shares, representing 13.5 per cent of the healthcare services company’s total equity, changed hands on the BSE, the exchange data shows. The names of the buyers were not ascertained immediately.
According to media reports, private equity giant Carlyle was set to sell stake in Metropolis Healthcare via block deal.
As on December 31, 2019, investor CA Lotus Investments, a subsidiary of US-based private equity firm Carlyle Group, held 7.18 million shares, or 14.31 per cent stake, in Metropolis Healthcare, the shareholding pattern data shows.
The stock has corrected 45 per cent from its all-time high level of Rs 2,110, touched on March 3, 2020. The company had debuted at the bourses in April last year after raising Rs 1,204 crore through its initial public offering (IPO), at issue price of Rs 880 per share.
At 09:30 am, Metropolis Healthcare was trading 10 per cent lower at Rs 1,203 on the BSE, as compared to 1.6 per cent rise in the S&P BSE Sensex. A combined 78.7 million shares have changed hands on the counter on the NSE and BSE so far.